Payment overview · 2025
General Payments
$270.54
14 reported records · 3 companies
Healthcare provider profile · identity verified
Grigoriy Goldenberg, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine · BROOKLYN, NY · NPI 1093784837
Verified facts
What the public records show
CMS Open Payments records show Grigoriy Goldenberg, M.D. received $270.54 in general payments during 2025 across 14 reported records.
Salix Pharmaceuticals, a division of Bausch Health US, LLC accounted for 73.2% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 4 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Otezla, Xifaxan.
Amgen Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported OTEZLA as an associated drug or biological on 177267 records involving 48600 distinct recipient NPIs. Public Medicare Part D data also shows 13 claims for Otezla by this doctor in 2024.
Amgen Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported PROLIA as an associated drug or biological on 20867 records involving 11744 distinct recipient NPIs. Public Medicare Part D data also shows 56 claims for Prolia by this doctor in 2024.
Salix Pharmaceuticals, a division of Bausch Health US, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported TRULANCE as an associated drug or biological on 2652 records involving 1501 distinct recipient NPIs. Public Medicare Part D data also shows 86 claims for Trulance by this doctor in 2024.
Salix Pharmaceuticals, a division of Bausch Health US, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported XIFAXAN as an associated drug or biological on 101901 records involving 33018 distinct recipient NPIs. Public Medicare Part D data also shows 16 claims for Xifaxan by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | Unresolved — no canonical attribution shown | $197.98 | 73.2% | 11 | 2025 |
| Amgen Inc. | Unresolved — no canonical attribution shown | $38.44 | 14.2% | 2 | 2025 |
| Ardelyx, Inc. | Unresolved — no canonical attribution shown | $34.12 | 12.6% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $270.54 | 14 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| XIFAXAN Normalized: xifaxan |
Drug | Salix Pharmaceuticals, a division of Bausch Health US, LLC | $197.98 | 11 | 2025 |
Source payment records
|
|||||
| OTEZLA Normalized: otezla |
Drug | Amgen Inc. | $38.44 | 2 | 2025 |
Source payment records
|
|||||
| REPATHA Normalized: repatha |
Biological | Amgen Inc. | $38.44 | 2 | 2025 |
Source payment records
|
|||||
| IBSRELA Normalized: ibsrela |
Drug | Ardelyx, Inc. | $34.12 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| OTEZLA otezla |
2025 | Otezla | 2024 | 13 Beneficiary count suppressed |
exact normalized | Medicare Part D |
| XIFAXAN xifaxan |
2025 | Xifaxan | 2024 | 16 Beneficiary count suppressed |
exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Amgen Inc. Exact reporting entity; no affiliate inference |
2025 | OTEZLA open payments reported associated product |
CMS Open Payments — General Payments 177267 supporting records · 48600 recipient NPIs · example record 1226871616 |
Otezla · 2024 Exact normalized brand match · 1 Part D row |
13 | suppressed by CMS |
| Amgen Inc. Exact reporting entity; no affiliate inference |
2025 | PROLIA open payments reported associated product |
CMS Open Payments — General Payments 20867 supporting records · 11744 recipient NPIs · example record 1226874448 |
Prolia · 2024 Exact normalized brand match · 1 Part D row |
56 | 38 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC Exact reporting entity; no affiliate inference |
2025 | TRULANCE open payments reported associated product |
CMS Open Payments — General Payments 2652 supporting records · 1501 recipient NPIs · example record 1231775445 |
Trulance · 2024 Exact normalized brand match · 1 Part D row |
86 | 15 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC Exact reporting entity; no affiliate inference |
2025 | XIFAXAN open payments reported associated product |
CMS Open Payments — General Payments 101901 supporting records · 33018 recipient NPIs · example record 1231775337 |
Xifaxan · 2024 Exact normalized brand match · 1 Part D row |
16 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Rosuvastatin Calcium | Rosuvastatin Calcium | 875 | 131 |
| Metoprolol Succinate | Metoprolol Succinate | 588 | 85 |
| Clopidogrel | Clopidogrel Bisulfate | 493 | 68 |
| Pantoprazole Sodium | Pantoprazole Sodium | 476 | 78 |
| Carvedilol | Carvedilol | 454 | 67 |
| Clonidine | Clonidine | 448 | 60 |
| Eliquis | Apixaban | 429 | 62 |
| Metformin Hcl | Metformin Hcl | 391 | 55 |
| Levothyroxine Sodium | Levothyroxine Sodium | 381 | 53 |
| Losartan Potassium | Losartan Potassium | 371 | 60 |
| Gabapentin | Gabapentin | 331 | 55 |
| Tamsulosin Hcl | Tamsulosin Hcl | 285 | 45 |
| Atorvastatin Calcium | Atorvastatin Calcium | 278 | 48 |
| Diclofenac Sodium | Diclofenac Sodium | 270 | 60 |
| Jardiance | Empagliflozin | 249 | 29 |
| Trazodone Hcl | Trazodone Hcl | 230 | 51 |
| Torsemide | Torsemide | 216 | 31 |
| Synthroid | Levothyroxine Sodium | 210 | 20 |
| Amlodipine Besylate | Amlodipine Besylate | 201 | 36 |
| Dexlansoprazole Dr | Dexlansoprazole | 198 | 31 |
| Allopurinol | Allopurinol | 189 | 25 |
| Linzess | Linaclotide | 189 | 28 |
| Doxazosin Mesylate | Doxazosin Mesylate | 185 | 45 |
| Omeprazole | Omeprazole | 176 | 42 |
| Pravastatin Sodium | Pravastatin Sodium | 176 | 35 |
| Escitalopram Oxalate | Escitalopram Oxalate | 170 | 36 |
| Hydralazine Hcl | Hydralazine Hcl | 170 | 70 |
| Zenpep | Lipase/Protease/Amylase | 170 | 30 |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 168 | 28 |
| Nifedipine Er | Nifedipine | 162 | 21 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 161 | 27 |
| Memantine Hcl | Memantine Hcl | 159 | 23 |
| Entresto | Sacubitril/Valsartan | 152 | 26 |
| Prazosin Hcl | Prazosin Hcl | 152 | 27 |
| Hydrochlorothiazide | Hydrochlorothiazide | 151 | 28 |
| Trulicity | Dulaglutide | 150 | 20 |
| Finasteride | Finasteride | 139 | 19 |
| Spironolactone | Spironolactone | 136 | 19 |
| Creon | Lipase/Protease/Amylase | 127 | 28 |
| Metolazone | Metolazone | 122 | 24 |
| Quetiapine Fumarate | Quetiapine Fumarate | 121 | 24 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 114 | 22 |
| Sertraline Hcl | Sertraline Hcl | 112 | 15 |
| Ezetimibe | Ezetimibe | 109 | 20 |
| Nateglinide | Nateglinide | 105 | 19 |
| Fluticasone Propionate | Fluticasone Propionate | 103 | 32 |
| Vascepa | Icosapent Ethyl | 102 | 16 |
| Chlorthalidone | Chlorthalidone | 94 | 16 |
| Pregabalin | Pregabalin | 93 | 19 |
| Lidocaine | Lidocaine | 90 | 21 |
| Repatha Sureclick | Evolocumab | 90 | 12 |
| Zolpidem Tartrate | Zolpidem Tartrate | 90 | 16 |
| Mirtazapine | Mirtazapine | 89 | 15 |
| Citalopram Hbr | Citalopram Hydrobromide | 87 | 17 |
| Nadolol | Nadolol | 87 | suppressed |
| Trulance | Plecanatide | 86 | 15 |
| Glimepiride | Glimepiride | 84 | suppressed |
| Atenolol | Atenolol | 82 | 15 |
| Memantine Hcl Er | Memantine Hcl | 82 | 16 |
| Bumetanide | Bumetanide | 81 | 22 |
| Galantamine Hbr | Galantamine Hbr | 77 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 76 | suppressed |
| Nitroglycerin Patch | Nitroglycerin | 75 | 20 |
| Celecoxib | Celecoxib | 73 | 21 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 72 | 14 |
| Fenofibrate | Fenofibrate Nanocrystallized | 72 | suppressed |
| Hydrocortisone | Hydrocortisone | 72 | 26 |
| Praluent Pen | Alirocumab | 70 | 13 |
| Valsartan | Valsartan | 70 | 12 |
| Famotidine | Famotidine | 69 | 17 |
| Ropinirole Hcl | Ropinirole Hcl | 69 | 12 |
| Metoprolol Tartrate | Metoprolol Tartrate | 68 | 11 |
| Furosemide | Furosemide | 67 | 16 |
| Ozempic | Semaglutide | 67 | 12 |
| Warfarin Sodium | Warfarin Sodium | 65 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 63 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 63 | 11 |
| Xarelto | Rivaroxaban | 58 | suppressed |
| Guanfacine Hcl | Guanfacine Hcl | 57 | suppressed |
| Glipizide | Glipizide | 56 | suppressed |
| Prolia | Denosumab | 56 | 38 |
| Alcohol Prep Pads | Alcohol Antiseptic Pads | 55 | 15 |
| Eplerenone | Eplerenone | 54 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 52 | suppressed |
| Calcitriol | Calcitriol | 52 | suppressed |
| Ranolazine Er | Ranolazine | 49 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 48 | suppressed |
| Dutasteride | Dutasteride | 48 | suppressed |
| Clotrimazole | Clotrimazole | 46 | 14 |
| Farxiga | Dapagliflozin Propanediol | 46 | suppressed |
| Ammonium Lactate | Ammonium Lactate | 45 | 12 |
| Dapagliflozin | Dapagliflozin Propanediol | 45 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 45 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 44 | suppressed |
| Myrbetriq | Mirabegron | 44 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 43 | suppressed |
| Lisinopril | Lisinopril | 43 | 12 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 43 | suppressed |
| Silver Sulfadiazine | Silver Sulfadiazine | 43 | 15 |
| Azithromycin | Azithromycin | 42 | 31 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 41 | suppressed |
| Mounjaro | Tirzepatide | 41 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 41 | suppressed |
| Mupirocin | Mupirocin | 40 | 13 |
| Buspirone Hcl | Buspirone Hcl | 39 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 39 | suppressed |
| Telmisartan | Telmisartan | 39 | suppressed |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 37 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 37 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 37 | suppressed |
| Ibuprofen | Ibuprofen | 36 | suppressed |
| Lorazepam | Lorazepam | 36 | 16 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 36 | suppressed |
| Tradjenta | Linagliptin | 36 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 35 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 35 | 11 |
| Icosapent Ethyl | Icosapent Ethyl | 34 | suppressed |
| Glipizide Er | Glipizide | 33 | suppressed |
| Lactulose | Lactulose | 33 | 13 |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 32 | suppressed |
| Easy Touch Alcohol Prep Pads | Alcohol Antiseptic Pads | 32 | suppressed |
| Fenofibrate | Fenofibrate | 32 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 32 | suppressed |
| Neupro | Rotigotine | 32 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 32 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 31 | 28 |
| Aripiprazole | Aripiprazole | 30 | suppressed |
| Bupropion Xl | Bupropion Hcl | 30 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 30 | suppressed |
| Ketoconazole | Ketoconazole | 30 | suppressed |
| Rivastigmine | Rivastigmine | 30 | suppressed |
| Cefpodoxime Proxetil | Cefpodoxime Proxetil | 29 | 22 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 29 | suppressed |
| Nitroglycerin | Nitroglycerin | 29 | 16 |
| Nystop | Nystatin | 29 | suppressed |
| Repaglinide | Repaglinide | 29 | suppressed |
| Rexulti | Brexpiprazole | 29 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 28 | suppressed |
| Potassium Chloride | Potassium Chloride | 28 | suppressed |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 27 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 27 | 21 |
| Procto-Med Hc | Hydrocortisone | 27 | suppressed |
| Acetazolamide | Acetazolamide | 26 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 26 | suppressed |
| Mometasone Furoate | Mometasone Furoate | 26 | suppressed |
| Potassium Citrate Er | Potassium Citrate | 26 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 26 | suppressed |
| Rivastigmine | Rivastigmine Tartrate | 26 | suppressed |
| Lacosamide | Lacosamide | 25 | suppressed |
| Alprazolam | Alprazolam | 24 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 24 | suppressed |
| Verapamil Er | Verapamil Hcl | 24 | suppressed |
| Dexilant | Dexlansoprazole | 23 | suppressed |
| Folic Acid | Folic Acid | 23 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 23 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 23 | 22 |
| Insulin Syringe | Syringe And Needle,insulin,1ml | 22 | suppressed |
| Levetiracetam | Levetiracetam | 22 | suppressed |
| Pro Comfort Alcohol Pads | Alcohol Antiseptic Pads | 22 | suppressed |
| Dexamethasone | Dexamethasone | 21 | 16 |
| Edarbi | Azilsartan Medoxomil | 21 | suppressed |
| Enulose | Lactulose | 21 | suppressed |
| Lubiprostone | Lubiprostone | 21 | suppressed |
| Montelukast Sodium | Montelukast Sodium | 21 | suppressed |
| Nystatin | Nystatin | 21 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 21 | suppressed |
| Irbesartan | Irbesartan | 20 | suppressed |
| Januvia | Sitagliptin Phosphate | 20 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 19 | suppressed |
| Veltassa | Patiromer Calcium Sorbitex | 19 | suppressed |
| Betamethasone Dipropionate | Betamethasone Dipropionate | 18 | suppressed |
| Nyamyc | Nystatin | 18 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 18 | suppressed |
| Irbesartan-Hydrochlorothiazide | Irbesartan/Hydrochlorothiazide | 17 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 17 | suppressed |
| Quetiapine Fumarate Er | Quetiapine Fumarate | 17 | suppressed |
| Simvastatin | Simvastatin | 17 | suppressed |
| Telmisartan-Hydrochlorothiazid | Telmisartan/Hydrochlorothiazid | 17 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 16 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 16 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 16 | suppressed |
| Xifaxan | Rifaximin | 16 | suppressed |
| Alcohol Pads | Alcohol Antiseptic Pads | 15 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 15 | suppressed |
| Cinacalcet Hcl | Cinacalcet Hcl | 15 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 15 | 15 |
| Cyanocobalamin Injection | Cyanocobalamin (Vitamin B-12) | 15 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 15 | suppressed |
| Sotalol | Sotalol Hcl | 15 | suppressed |
| Galantamine Er | Galantamine Hbr | 14 | suppressed |
| Insulin Syringe | Syringe-Needle,insulin,0.5 Ml | 14 | suppressed |
| Metformin Er Gastric | Metformin Hcl | 14 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 14 | suppressed |
| Ramipril | Ramipril | 14 | suppressed |
| Carvedilol Er | Carvedilol Phosphate | 13 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 13 | suppressed |
| Colchicine | Colchicine | 13 | suppressed |
| Halobetasol Propionate | Halobetasol Propionate | 13 | suppressed |
| Jentadueto | Linagliptin/Metformin Hcl | 13 | suppressed |
| Lokelma | Sodium Zirconium Cyclosilicate | 13 | suppressed |
| Mupirocin | Mupirocin Calcium | 13 | suppressed |
| Otezla | Apremilast | 13 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 13 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 13 | suppressed |
| Proctozone-Hc | Hydrocortisone | 13 | suppressed |
| Sevelamer Carbonate | Sevelamer Carbonate | 13 | suppressed |
| Single Use Swab | Alcohol Antiseptic Pads | 13 | suppressed |
| Alcohol Swabs | Alcohol Antiseptic Pads | 12 | suppressed |
| Comfort Ez Pen Needle | Pen Needle, Diabetic | 12 | suppressed |
| Prasugrel Hcl | Prasugrel Hcl | 12 | suppressed |
| Rizatriptan | Rizatriptan Benzoate | 12 | suppressed |
| Ssd | Silver Sulfadiazine | 12 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 12 | suppressed |
| Constulose | Lactulose | 11 | suppressed |
| Digoxin | Digoxin | 11 | suppressed |
| Gemfibrozil | Gemfibrozil | 11 | suppressed |
| Levofloxacin | Levofloxacin | 11 | suppressed |
| Novolog Flexpen | Insulin Aspart | 11 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 11 | suppressed |
| Ultra Comfort | Syringe And Needle,insulin,1ml | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $270.54 · 14 records | Salix Pharmaceuticals, a division of Bausch Health US, LLC | IBSRELA, OTEZLA, REPATHA, XIFAXAN | 4 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Otezla play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with Amgen Inc.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error